AnaptysBio (ANAB) Stock Chart & Stock Price History $21.41 -1.99 (-8.50%) As of 02:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AnaptysBio Stock Price Performance The AnaptysBio (ANAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 46.91%, with a year-to-date return of 61.71%. In the past month, the stock has increased 6.31%, reflecting recent market activity. As of the latest close, AnaptysBio traded at $23.40 with a market cap of $655.13 million and volume of 472,652 shares. Five years ago, the stock traded at $15.54, representing a 37.77% increase over that period. At the time, it had a market cap of $413.10 million and a volume of 334,649 shares. Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-6.01%1 Month Performance+6.31%3 Month Performance-8.19%Year-To-Date Performance+61.71%1 Year Performance-46.91%5 Year Performance+37.77% ANAB Stock Chart for Monday, September, 15, 2025 ANAB Chart by TradingView AnaptysBio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/12/2025$23.20$23.40+0.86%$23.58$22.87472,652 shs$655.13 million09/11/2025$22.78$23.20+1.84%$23.64$22.78425,402 shs$649.60 million09/10/2025$22.13$22.78+2.94%$22.80$22.01499,011 shs$637.84 million09/09/2025$22.19$22.13-0.27%$22.32$21.88368,991 shs$619.57 million09/08/2025$21.90$22.19+1.32%$22.65$21.56607,096 shs$621.32 million09/05/2025$21.09$21.90+3.84%$22.30$20.61402,655 shs$613.20 million09/04/2025$22.53$21.09-6.39%$22.98$20.82537,177 shs$590.52 million09/03/2025$20.61$22.53+9.32%$22.57$20.36728,097 shs$630.77 million09/02/2025$20.33$20.61+1.38%$20.99$20.35188,250 shs$577.08 million09/01/2025$20.33$20.33$20.51$19.86322,607 shs$569.24 million Get the Latest News and Ratings for ANAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. 08/29/2025$20.13$20.33+0.99%$20.51$19.86322,607 shs$569.24 million08/28/2025$20.40$20.13-1.32%$20.81$20.07503,622 shs$563.58 million08/27/2025$19.96$20.40+2.20%$20.43$19.71680,327 shs$571.20 million08/26/2025$20.10$19.96-0.70%$20.22$19.68298,143 shs$558.88 million08/25/2025$20.22$20.10-0.59%$20.40$19.88206,440 shs$562.74 million08/22/2025$20.36$20.22-0.69%$21.04$20.09257,922 shs$566.10 million08/21/2025$20.15$20.36+1.04%$20.57$19.60595,827 shs$570.08 million08/20/2025$19.79$20.15+1.82%$20.47$19.48370,676 shs$564.20 million08/19/2025$20.02$19.79-1.15%$20.25$19.52348,892 shs$554.06 million08/18/2025$20.14$20.02-0.60%$20.35$19.93216,479 shs$560.56 million08/15/2025$19.97$20.14+0.85%$20.22$19.63547,616 shs$563.92 million08/14/2025$20.72$19.97-3.62%$20.42$19.68344,933 shs$559.16 million Related Companies Tarsus Pharmaceuticals Stock Chart IDEAYA Biosciences Stock Chart Ocular Therapeutix Stock Chart Mineralys Therapeutics Stock Chart ImmunityBio Stock Chart Denali Therapeutics Stock Chart Disc Medicine Stock Chart Beam Therapeutics Stock Chart Centessa Pharmaceuticals Stock Chart Belite Bio Stock Chart Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANAB) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AnaptysBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANAB Stock Alerts